Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

NSE:INDRAMEDCO Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	1,610	1,240	861.5	586.2	23.3
Depreciation & Amortization	443.3	394.6	378.4	332.7	318.8
Other Amortization	-	6.2	14.3	16.7	14.4
Loss (Gain) From Sale of Assets	5.2	11.7	8.7	57.7	7.1
Other Operating Activities	-252.9	-205.2	115.2	-15.8	-72.8
Change in Accounts Receivable	-193.6	138.7	-234.9	259.5	85.3
Change in Inventory	5.4	9.2	15.4	-12.5	33.3
Change in Accounts Payable	-49.8	406.7	286.1	-281.5	-141.3
Operating Cash Flow	1,568	2,002	1,445	943	268.1
Operating Cash Flow Growth	-21.68%	38.54%	53.20%	251.73%	-68.99%
Capital Expenditures	-363.3	-693.9	-445.8	-294.8	-209.6
Other Investing Activities	-746.6	-890.4	-633.3	-446.3	18.8
Investing Cash Flow	-1,110	-1,584	-1,079	-741.1	-190.8
Long-Term Debt Repaid	-21.3	-37.9	-28.3	-25.1	-20.9
Total Debt Repaid	-21.3	-37.9	-28.3	-25.1	-20.9
Net Debt Issued (Repaid)	-21.3	-37.9	-28.3	-25.1	-20.9
Common Dividends Paid	-407.3	-275.4	-228.4	-2.6	-2.4
Other Financing Activities	-30.2	-10.5	-3.7	-6	-8.1
Financing Cash Flow	-458.8	-323.8	-260.4	-33.7	-31.4
Net Cash Flow	-1.2	93.4	105.2	168.2	45.9
Free Cash Flow	1,204	1,308	998.9	648.2	58.5
Free Cash Flow Growth	-7.91%	30.90%	54.10%	1008.03%	-87.15%
Free Cash Flow Margin	8.88%	10.51%	9.09%	7.30%	0.95%
Free Cash Flow Per Share	13.13	14.26	10.90	7.07	0.64
Cash Interest Paid	30.3	10.6	4.6	6.1	8.1
Cash Income Tax Paid	609.8	468.3	98.5	195.1	93.7
Levered Free Cash Flow	1,185	1,139	956.2	606.55	16.31
Unlevered Free Cash Flow	1,225	1,146	959.08	610.36	16.31
Change in Net Working Capital	105	-473.3	-310.3	-23.7	155.17

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.